QT
TXG icon

Quantbot Technologies’s 10x Genomics TXG Stock Holding History

Quantbot Technologies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-64,065
Closed -$1.04M – 2174
2025
Q4 		$1.04M Buy
+64,065
New +$968K 0.03% 682
2025
Q1 		– Sell
-71,429
Closed -$1.03M – 1883
2024
Q4 		$1.03M Buy
+71,429
New +$1.13M 0.04% 620
2024
Q3 		– Sell
-44,725
Closed -$870K – 1847
2024
Q2 		$870K Sell
44,725
-33,616
-43% -$880K 0.04% 579
2024
Q1 		$2.94M Buy
+78,341
New +$3.44M 0.17% 164
2023
Q4 		– Sell
-21,604
Closed -$891K – 2009
2023
Q3 		$891K Buy
21,604
+3,444
+19% +$179K 0.06% 454
2023
Q2 		$1.01M Buy
+18,160
New +$983K 0.07% 444
2021
Q1 		– Sell
-12,318
Closed -$1.74M – 1766
2020
Q4 		$1.74M Buy
+12,318
New +$1.79M 0.18% 163
2020
Q2 		– Sell
-700
Closed -$43K – 1453
2020
Q1 		$43K Buy
+700
New +$54.6K 0.03% 467

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's TXG Position: Q1 2026 in Review

Quantbot Technologies sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 64,065 shares — an estimated $1.04M sold.

Quantbot Technologies first reported a position in TXG in Q1 2020 and held it in 8 quarters. The position peaked at $2.94M in Q1 2024. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Quantbot Technologies reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 64,065 10x Genomics shares in Q1 2026, an estimated $1.04M.
  • Quantbot Technologies first reported a position in 10x Genomics in Q1 2020 and held it in 8 quarters.
  • Quantbot Technologies's 10x Genomics position peaked at $2.94M in Q1 2024.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.